ロード中...
Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy
BACKGROUND: Resistance to modern adjuvant treatment is in part due to the failure of programmed cell death. Therefore the molecules that execute the apoptotic program are potential targets for the development of anti-cancer therapeutics. The sigma-2 receptor has been found to be over-expressed in so...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2007
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1939854/ https://ncbi.nlm.nih.gov/pubmed/17631687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-6-48 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|